ArticleBlood advances2023

Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

Amy D Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.